Hematology-in-Focus Sessions

HEMATOLOGY-IN-FOCUS
09:30 – 10:15, Hall 2

VACCINATION THERAPY

Chair: C Chomienne (Hôpital Saint Louis, Paris, France)

• WT-1 PEPTIDE VACCINE
  Y Oka (Graduate School of Medicine – Osaka University, Osaka, Japan)
• PR PEPTIDE VACCINE
  J Molldrem (M.D. Anderson Cancer Center, Houston, USA)

HEMATOLOGY-IN-FOCUS
09:30 – 10:15, Hall 3

MYELOMA MICROENVIRONMENT

Chair: I van Riet (University Hospital Brussels, Brussels, Belgium)

• THE ROLE OF MICROENVIRONMENT IN MULTIPLE MYELOMA
  M Børset (Norwegian University of Science and Technology / St. Olav’s Hospital, Trondheim, Norway)
• MICROENVIRONMENT OF ANGIOGENESIS
  A Vacca (University of Bari, Bari, Italy)

HEMATOLOGY-IN-FOCUS
09:30 – 10:15, Hall 15.2

REGULATORY T CELLS IN STEM CELL TRANSPLANTATION

Chair: M Manz (Institute for Research in Biomedicine, Bellinzona, Switzerland)

• THE IMMUNOBIOLOGY OF T REGULATORY CELLS IN HEALTH, DISEASE, AND TRANSPLANTATION TOLERANCE
  H Waldmann (Sir William Dunn School of Pathology, Oxford, United Kingdom)
• T REGULATORY CELL-BASED PROPHYLAXIS AND THERAPY OF GVHD
  M Edinger (University Hospital Regensburg, Regensburg, Germany)

HEMATOLOGY-IN-FOCUS
09:30 – 10:15, Hall 2.1 (stage)

MONOCLONAL B-LYMPHOCYTOSIS

Chair: P Ghia (Università Vita-Salute San Raffaele, Milan, Italy)

• IS MONOCLONAL B-LYMPHOCYTOSIS A TRUE PRE-LEUKEMIC DISEASE?
  A Rawstron (St. James’s Institute of Oncology, Leeds, United Kingdom)
• NATURAL HISTORY OF MONOCLONAL B-LYMPHOCYTOSIS
  O Landgren (National Institute of Health, Bethesda, USA)

HEMATOLOGY-IN-FOCUS
09:30 – 10:15, Hall 7

VIRUS INDUCED LYMPHOMAS

VIRUS INDUCED LYMPHOMAS

• THE ROLE OF EPSTEIN BARR VIRUS IN TRANSFORMING B-CELLS
  D Thorley-Lawson (Tufts University School of Medicine, Boston, USA)
• THE MODEL OF HTLV-1 TRANSFORMATION OF T-LYMPHOCYTES
  E Wattel (Hôpital Edouard Herriot, Lyon, France)
  

HEMATOLOGY-IN-FOCUS
09:30 – 10:15, Hall 14.2

CONGENITAL BONE MARROW FAILURE SYNDROMES

Chair: K Welte (Medical School Hannover - Children Hospital, Hannover,Germany)

• TELOMERES AND RIBOSOMES IN BONE MARROW FAILURE
  M Bessler (Washington University St. Louis, St. Louis, USA)
• INSIGHTS FROM MODEL ORGANISMS
  P Mason (Washington University, St. Louis, USA)

HEMATOLOGY-IN-FOCUS
09:30 – 10:15, Hall 4/5

GENE COPY VARIATION IN ACUTE LEUKEMIA

Chair: G Salles (Centre Hospitalier Lyon Sud, Lyon, France)

• GENE COPY NUMBER ALTERATIONS IN ACUTE MYELOID LEUKEMIA
  B Young (Institute of Cancer, London, United Kingdom)
• GENE COPY NUMBER ALTERATIONS IN ACUTE LYMPHOBLASTIC LEUKEMIA
  J Soulier (Hôpital Saint Louis, Paris, France)

HEMATOLOGY-IN-FOCUS
09:30 – 10:15, Hall 6

NOTCH1 IN MALIGNANT AND NORMAL T-CELLS

Chair: J Cools (K.U. Leuven – VIB, Leuven, Belgium)

• NOTCH1 IN NORMAL AND MALIGNANT T-CELLS
  F Pflumio (Institut de Radiobiologie Cellulaire e Moléculaire, Fontenay-aux-Roses, France)
• NOTCH1 TARGETING IN T-ACUTE LYMPHOBLASTIC LEUKEMIA
  A Ferrando (Columbia University, New York, USA)